Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

NCT04416581 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

3320

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Myocardial Infarction

Interventions

DRUG: PPI
DRUG: P-CAB 50

Sponsor

Duk-Woo Park, MD